Merck (MRK) PT Raised to $95 at Cowen on Gefapixant Data

September 8, 2020 6:59 AM
Cowen analyst Steve Scala raised the price target on Merck (NYSE: MRK) to $95.00 (from $88.00) after the presented full ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change